日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Retraction Note: Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders

撤稿声明:间充质干/基质细胞是治疗免疫介导疾病的重要来源

Markov, Alexander; Thangavelu, Lakshmi; Aravindhan, Surendar; Zekiy, Angelina Olegovna; Jarahian, Mostafa; Chartrand, Max Stanley; Pathak, Yashwant; Marofi, Faroogh; Shamlou, Somayeh; Hassanzadeh, Ali

CAR T cells in solid tumors: challenges and opportunities

CAR-T细胞在实体瘤中的应用:挑战与机遇

Marofi, Faroogh; Motavalli, Roza; Safonov, Vladimir A; Thangavelu, Lakshmi; Yumashev, Alexei Valerievich; Alexander, Markov; Shomali, Navid; Chartrand, Max Stanley; Pathak, Yashwant; Jarahian, Mostafa; Izadi, Sepideh; Hassanzadeh, Ali; Shirafkan, Naghmeh; Tahmasebi, Safa; Khiavi, Farhad Motavalli

Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders

间充质干/基质细胞是治疗免疫介导疾病的重要来源

Markov, Alexander; Thangavelu, Lakshmi; Aravindhan, Surendar; Zekiy, Angelina Olegovna; Jarahian, Mostafa; Chartrand, Max Stanley; Pathak, Yashwant; Marofi, Faroogh; Shamlou, Somayeh; Hassanzadeh, Ali

Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism

多发性骨髓瘤的治疗距离成功更近了一步吗?CAR-T细胞疗法是一个令人乐观的理由。

Marofi, Faroogh; Tahmasebi, Safa; Rahman, Heshu Sulaiman; Kaigorodov, Denis; Markov, Alexander; Yumashev, Alexei Valerievich; Shomali, Navid; Chartrand, Max Stanley; Pathak, Yashwant; Mohammed, Rebar N; Jarahian, Mostafa; Motavalli, Roza; Motavalli Khiavi, Farhad

Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities

间充质干/基质细胞来源的外泌体在再生医学和癌症中的应用:发展、挑战和机遇概述

Hassanzadeh, Ali; Rahman, Heshu Sulaiman; Markov, Alexander; Endjun, Judi Januadi; Zekiy, Angelina Olegovna; Chartrand, Max Stanley; Beheshtkhoo, Nasrin; Kouhbanani, Mohammad Amin Jadidi; Marofi, Faroogh; Nikoo, Marzieh; Jarahian, Mostafa

Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism

更正:多发性骨髓瘤的成功治疗更进一步了吗?CAR-T细胞疗法是令人乐观的有力理由。

Marofi, Faroogh; Tahmasebi, Safa; Rahman, Heshu Sulaiman; Kaigorodov, Denis; Markov, Alexander; Yumashev, Alexei Valerievich; Shomali, Navid; Chartrand, Max Stanley; Pathak, Yashwant; Mohammed, Rebar N; Jarahian, Mostafa; Motavalli, Roza; Khiavi, Farhad Motavalli

Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy

CAR-NK细胞这种“装甲免疫效应细胞”的复兴,为癌症治疗的成功带来了更大的希望。

Marofi, Faroogh; Rahman, Heshu Sulaiman; Thangavelu, Lakshmi; Dorofeev, Aleksey; Bayas-Morejón, Favian; Shirafkan, Naghmeh; Shomali, Navid; Chartrand, Max Stanley; Jarahian, Mostafa; Vahedi, Ghasem; Mohammed, Rebar N; Shahrokh, Somayeh; Akbari, Morteza; Khiavi, Farhad Motavalli

Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients

新型CAR-T疗法为重症急性髓系白血病(AML)患者的治疗带来了一线希望。

Marofi, Faroogh; Rahman, Heshu Sulaiman; Al-Obaidi, Zaid Mahdi Jaber; Jalil, Abduladheem Turki; Abdelbasset, Walid Kamal; Suksatan, Wanich; Dorofeev, Aleksei Evgenievich; Shomali, Navid; Chartrand, Max Stanley; Pathak, Yashwant; Hassanzadeh, Ali; Baradaran, Behzad; Ahmadi, Majid; Saeedi, Hossein; Tahmasebi, Safa; Jarahian, Mostafa

CAR-NK cell in cancer immunotherapy; A promising frontier

CAR-NK细胞在癌症免疫疗法中的应用:一个充满希望的前沿领域

Marofi, Faroogh; Abdul-Rasheed, Omar F; Rahman, Heshu Sulaiman; Budi, Hendrik Setia; Jalil, Abduladheem Turki; Yumashev, Alexei Valerievich; Hassanzadeh, Ali; Yazdanifar, Mahboubeh; Motavalli, Roza; Chartrand, Max Stanley; Ahmadi, Majid; Cid-Arreguid, Angel; Jarahian, Mostafa

Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy

间充质干细胞/基质细胞递送:一种快速发展的癌症治疗策略

Hassanzadeh, Ali; Altajer, Amjad Hussein; Rahman, Heshu Sulaiman; Saleh, Marwan Mahmood; Bokov, Dmitry O; Abdelbasset, Walid Kamal; Marofi, Faroogh; Zamani, Majid; Yaghoubi, Yoda; Yazdanifar, Mahboubeh; Pathak, Yashwant; Chartrand, Max Stanley; Jarahian, Mostafa